1. F24 Design of a prospective, longitudinal, natural history study in huntington's disease. (September 2018) Authors: Hooper, Gregory; Trundell, Dylan; Palermo, Giuseppe; Kremer, Thomas; Frick, Elsbeth; Boak, Lauren; Doody, Rachelle; Schobel, Scott Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 89(2018)Supplement 1 Page Start: A48 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Clinical utility of a blood-based EGFR mutation test in patients receiving first-line erlotinib therapy in the ENSURE, FASTACT-2, and ASPIRATION studies. (December 2018) Authors: Wu, Yi-Long; Lee, Victor; Liam, Chong-Kin; Lu, Shun; Park, Keunchil; Srimuninnimit, Vichien; Wang, Jie; Zhou, Caicun; Appius, Anita; Button, Peter; Hooper, Gregory; Palma, John F.; Schulze, Katja; Scudder, Sidney; Shames, David S.; Yin, Anny-Yue; Zhang, Guili; Mok, Tony Journal: Lung cancer Issue: Volume 126(2018) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Maintenance erlotinib versus erlotinib at disease progression in patients with advanced non-small-cell lung cancer who have not progressed following platinum-based chemotherapy (IUNO study). (December 2016) Authors: Cicènas, Saulius; Geater, Sarayut Lucien; Petrov, Petar; Hotko, Yevgeniy; Hooper, Gregory; Xia, Fan; Mudie, Nadejda; Wu, Yi-Long Journal: Lung cancer Issue: Volume 102(2016) Page Start: 30 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗